Genomadix

genomadix.com

Genomadix is a biotechnology company that has developed the Genomadix Cube, a real-time PCR point-of-need platform for precision medicine testing and environmental safety. The company specializes in molecular tests, including the FDA-cleared CYP2C19 Genotyping Test, which supports dual antiplatelet therapy decisions for stroke and cardiology patients. With over 3 million hours of R&D and 11 patents, Genomadix differentiates itself through its rapid testing capabilities and partnerships with clinical labs and assay developers. The company is positioned for growth in the precision medicine market, leveraging its innovative technology and experienced leadership team.